284 results match your criteria: "London Centre for Neglected Tropical Disease Research[Affiliation]"

The relative contributions of exposure vs. acquired immunity to the epidemiology of human schistosomiasis has been long debated. While there is considerable evidence that humans acquire partial immunity to infection, age- and sex-related contact patterns with water bodies contaminated with infectious cercarial schistosome larvae also contribute to typical epidemiological profiles of infection.

View Article and Find Full Text PDF

The epidemiology of Chagas disease in the Americas.

Lancet Reg Health Am

September 2024

Instituto Leônidas e Maria Deane - Fiocruz Amazônia, Manaus, Brazil.

Chagas disease is a complex parasitic zoonosis that still threatens public health across the Americas. Initiatives to control transmission blood transfusion and non-native triatomine-bug vectors have yielded crucial advances; native vectors, however, actively bridge wild and domestic/peri-domestic transmission cycles throughout the region, and tens of thousands of people become infected each year. Oral-transmission outbreaks, urbanisation, and vertical transmission are additional/emerging issues calling for innovative strategic thinking.

View Article and Find Full Text PDF

Comparison of diagnostic tools to assess the feasibility of programmatic use of rapid diagnostic tests for onchocerciasis: A dataset from Gabon.

Data Brief

December 2024

MRC Centre for Global Infectious Disease Analysis and London Centre for Neglected Tropical Disease Research, School of Public Health, Imperial College London, London, UK.

Article Synopsis
  • The shift in onchocerciasis intervention aims from control to elimination of transmission has highlighted the need for better diagnostic tools in low-prevalence settings, a focus area not previously addressed in large-scale ivermectin mass drug administrations (MDA).
  • A comprehensive study in Gabon in 2015 involved 5,829 participants, gathering data through skin-snip and blood tests to assess the presence of microfilariae and IgG4 antibodies against the Ov16 antigen.
  • Results showed varying detection rates across diagnostics: skin-snip microscopy (8%), Ov16 RDT (9%), and Ov16 ELISA (12%), providing valuable data for policymakers and test manufacturers to evaluate community-level transmission status and improve MDA strategies
View Article and Find Full Text PDF

Mass-drug administration (MDA) of human populations using praziquantel monotherapy has become the primary strategy for controlling and potentially eliminating the major neglected tropical disease schistosomiasis. To understand how long-term MDA impacts schistosome populations, we analysed whole-genome sequence data of 570 samples (and the closely related outgroup species, from eight countries incorporating both publicly-available sequence data and new parasite material. This revealed broad-scale genetic structure across countries but with extensive transmission over hundreds of kilometres.

View Article and Find Full Text PDF

Background: This paper documents changes in the prevalence and intensity of soil-transmitted helminth (STH) infections in the Geshiyaro project in the Wolaita zone of Southern Ethiopia.

Methods: The Geshiyaro project comprises three intervention arms. Arm 1 is subdivided into the Arm 1 pilot (one district) and Arm 1 (four other districts), both receiving integrated community-wide mass drug administration MDA (cMDA) with intensive water, sanitation, and hygiene (WaSH) interventions.

View Article and Find Full Text PDF

Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence.

Nat Commun

July 2024

MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.

Article Synopsis
  • A study in Cameroon linked childhood exposure to the Onchocerca volvulus parasite with an increased risk of developing epilepsy later in life.
  • Researchers incorporated this relationship into an existing model, EPIONCHO-IBM, and simulated the effects of 19 years of ivermectin mass drug administration (MDA) on epilepsy rates.
  • Results showed that in highly endemic areas, 25 years of regular MDA could eliminate onchocerciasis-related epilepsy, emphasizing the need for improved treatment strategies for young children in those regions.
View Article and Find Full Text PDF
Article Synopsis
  • Mass drug administration (MDA) is essential for eliminating lymphatic filariasis (LF), and the rate of the population never treated (NT) significantly influences success.
  • *Using stochastic transmission models, the study explores acceptable NT levels needed to reach a 1% microfilaremia prevalence within 10 years under various treatment scenarios.
  • *Results indicate that in different transmission settings, maintaining low NT percentages while achieving at least 80% treatment coverage is crucial for effective elimination efforts.*
View Article and Find Full Text PDF

Background: Control of schistosomiasis (SCH) relies on the regular distribution of preventive chemotherapy (PC) over many years. For the sake of sustainable SCH control, a decision must be made at some stage to scale down or stop PC. These "stopping decisions" are based on population surveys that assess whether infection levels are sufficiently low.

View Article and Find Full Text PDF

How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?

Clin Infect Dis

April 2024

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, United Kingdom.

Article Synopsis
  • The goal for 2030 is to eliminate schistosomiasis as a public health issue, specifically targeting heavy-intensity infections in school-aged children to drop below 1%, with new guidelines extending this goal to include younger children and adults.
  • A study using two individual-based models examined the effectiveness of school-based vs. community-wide treatment strategies, determining the number of treatment rounds needed to reduce heavy infections, based on the percentage of the population that has never been treated (NT).
  • Results showed that in low to moderate transmission areas, EPHP can be achieved within 7 years if NT is below 10% or 5%, while high transmission areas require community-wide treatment with NT
View Article and Find Full Text PDF

An Updated Economic Assessment of Moxidectin Treatment Strategies for Onchocerciasis Elimination.

Clin Infect Dis

April 2024

UK Medical Research Council Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.

Background: Concerns that annual mass administration of ivermectin, the predominant strategy for onchocerciasis control and elimination, may not lead to elimination of parasite transmission (EoT) in all endemic areas have increased interest in alternative treatment strategies. One such strategy is moxidectin. We performed an updated economic assessment of moxidectin- relative to ivermectin-based strategies.

View Article and Find Full Text PDF

Over the past decade, considerable progress has been made in the control, elimination, and eradication of neglected tropical diseases (NTDs). Despite these advances, most NTD programs have recently experienced important setbacks; for example, NTD interventions were some of the most frequently and severely impacted by service disruptions due to the coronavirus disease 2019 (COVID-19) pandemic. Mathematical modeling can help inform selection of interventions to meet the targets set out in the NTD road map 2021-2030, and such studies should prioritize questions that are relevant for decision-makers, especially those designing, implementing, and evaluating national and subnational programs.

View Article and Find Full Text PDF

Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.

Lancet Glob Health

May 2024

Centre for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya; Paul G Allen School for Global Health, Washington State University, Pullman, WA, USA; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK.

Article Synopsis
  • The WHO aims to eliminate onchocerciasis (river blindness) transmission by 2030, predominantly affecting sub-Saharan Africa, and relies on vector control and mass drug administration of ivermectin for this effort.
  • A systematic review and meta-analysis was conducted to assess studies on onchocerciasis transmission status in sub-Saharan Africa, focusing on criteria such as the presence of elimination reports or long-term ivermectin administration.
  • The research involved a thorough search of multiple databases and included a classification system to determine the status of foci regarding transmission elimination, while employing mixed-effects meta-regression models to find contributing factors.
View Article and Find Full Text PDF

Progress in controlling the transmission of schistosome parasites in Southern Ethiopia: the Geshiyaro Project in the Wolaita Zone.

Parasit Vectors

March 2024

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Faculty of Medicine, St Marys Campus, Imperial College London, London, UK.

Background: This paper describes changes in the prevalence and intensity of schistosome parasite infections in a project integrating mass drug administration (MDA), water, sanitation, and hygiene (WaSH), and behavioral change interventions.

Methods: The Geshiyaro Project comprises three intervention arms. Arm 1 is subdivided into "Arm 1 pilot" (one district) and Arm 1 (four other districts), both receiving integrated community-wide MDA with intensive WaSH interventions.

View Article and Find Full Text PDF

Objectives: Deworming programmes of soil-transmitted helminths are generally monitored and evaluated by aggregating drug coverage and infection levels at a district level. However, heterogeneity in drug coverage at finer spatial scales means indicators may remain above thresholds for elimination as a public health problem or of transmission in some areas. This paper aims to highlight the misleading information that aggregating data at larger spatial scales can have for programme decision making.

View Article and Find Full Text PDF
Article Synopsis
  • - Lymphatic filariasis (LF) is a serious neglected tropical disease with ongoing global efforts to eliminate it as a public health problem, yet nearly 900 million people still need treatment despite over 9 billion treatments distributed since 2000.
  • - A systematic literature review was conducted to gather individual participant data (IPD) related to LF treatment effectiveness and morbidity management by analyzing studies from various databases between 2000 and 2023.
  • - From 138 eligible studies across 23 countries, researchers identified nearly 15,000 IPD related to infection indicators and approximately 6,100 IPD concerning clinical morbidity, revealing significant gaps in understanding treatment responses.
View Article and Find Full Text PDF
Article Synopsis
  • There is growing evidence linking onchocerciasis (a parasitic disease) to seizures, leading to the recognition of onchocerciasis-associated epilepsy (OAE) as a significant public health issue, especially in sub-Saharan Africa.
  • A recent workshop highlighted the need for a clear case definition of OAE and emphasized the importance of integrating epilepsy care into ongoing onchocerciasis elimination efforts to reduce the incidence of seizures.
  • Recommendations include enhancing collaboration between health programs, ensuring uninterrupted access to free anti-seizure medications in affected areas, and incorporating OAE into assessments of the overall onchocerciasis disease burden.
View Article and Find Full Text PDF

Background: The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount.

View Article and Find Full Text PDF

Accuracy of the direct agglutination test for diagnosis of visceral leishmaniasis: a systematic review and meta-analysis.

BMC Infect Dis

November 2023

Lao- Oxford-Mahosot Hospital- Wellcome Trust Research Unit, Mahosot Hospital, Mahosot Road, Vientiane, Lao People's Democratic Republic.

Background: Parasitological investigation of bone marrow, splenic or lymph node aspirations is the gold standard for the diagnosis of visceral leishmaniasis (VL). However, this invasive test requires skilled clinical and laboratory staff and adequate facilities, and sensitivity varies depending on the tissue used. The direct agglutination test (DAT) is a serological test that does not need specialised staff, with just minimal training required.

View Article and Find Full Text PDF

Modelling flock heterogeneity in the transmission of peste des petits ruminants virus and its impact on the effectiveness of vaccination for eradication.

Epidemics

December 2023

Veterinary Epidemiology, Economics and Public Health Group, WOAH Collaborating Centre for Risk Analysis and Modelling, Department of Pathobiology and Population Sciences, The Royal Veterinary College, London, UK; Université de Lyon, INRAE, VetAgro Sup, UMR EPIA, Marcy l'Etoile, France; Université Clermont Auvergne, INRAE, VetAgro Sup, UMR EPIA, Saint Genes Champanelle, France.

Peste des petits ruminants (PPR) is an acute infectious disease of small ruminants targeted for global eradication by 2030. The Global Strategy for Control and Eradication (GSCE) recommends mass vaccination targeting 70% coverage of small ruminant populations in PPR-endemic regions. These small ruminant populations are diverse with heterogeneous mixing patterns that may influence PPR virus (PPRV) transmission dynamics.

View Article and Find Full Text PDF

Background: The Geshiyaro project aims to assess the feasibility of interrupting transmission of soil-transmitted helminths (STH) and schistosome (SCH) infection in the Wolaita zone of southern Ethiopia through high coverage community-wide mass drug administration (MDA), in combination with improved water, sanitation, and hygiene services and behaviour change communication delivered through the existing health care infrastructure. To accurately measure treatment coverage a population census was conducted enrolling individuals with biometric fingerprinting and barcoded ID cards. This paper details the baseline census and parasitology surveys conducted before the start of any interventions.

View Article and Find Full Text PDF

Objectives: There is a pressing need to regularly evaluate the progress of onchocerciasis elimination programmes to timely identify and mitigate potential risks hindering the reaching of the 2030 targets proposed by the World Health Organization (WHO) in its roadmap on neglected tropical diseases (NTDs). We determined the prevalence of onchocerciasis and associated dermatological and ophthalmological manifestations in six endemic communities in the Bono Region of Ghana after 27 years of ivermectin mass treatment.

Methods: In a cross-sectional study, 564 participants aged ≥5 years were enrolled (49.

View Article and Find Full Text PDF

The long road to schistosomiasis elimination in Zanzibar: A systematic review covering 100 years of research, interventions and control milestones.

Adv Parasitol

September 2023

Natural History Museum, London, United Kingdom; London Centre for Neglected Tropical Disease Research, London, United Kingdom; Western University of Health Sciences, Lebanon, OR, United States. Electronic address:

Article Synopsis
  • Zanzibar has made significant progress in schistosomiasis control, achieving a reduction in Schistosoma haematobium prevalence from over 50% to below 5% in 2020, improving the health of its population.
  • The systematic review of 153 records from 1928 to 2022 highlights key milestones, remaining challenges, and the importance of integrated interventions for the elimination of urogenital schistosomiasis.
  • With ongoing commitments and focused strategies, achieving the interruption of S. haematobium transmission by 2030 is a realistic goal, potentially influencing broader efforts across sub-Saharan Africa.
View Article and Find Full Text PDF

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

Philos Trans R Soc Lond B Biol Sci

October 2023

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.

Epidemiological and modelling studies suggest that elimination of transmission (EoT) throughout Africa may not be achievable with annual mass drug administration (MDA) of ivermectin alone, particularly in areas of high endemicity and vector density. Single-dose Phase II and III clinical trials demonstrated moxidectin's superiority over ivermectin for prolonged clearance of microfilariae. We used the stochastic, individual-based EPIONCHO-IBM model to compare the probabilities of reaching EoT between ivermectin and moxidectin MDA for a range of endemicity levels (30 to 70% baseline microfilarial prevalence), treatment frequencies (annual and biannual) and therapeutic coverage/adherence values (65 and 80% of total population, with, respectively, 5 and 1% of systematic non-adherence).

View Article and Find Full Text PDF
Article Synopsis
  • The World Health Organization aimed to eliminate intradomiciliary transmission of Chagas disease by 2020, but set new, more ambitious goals for 2021-2030 due to limited progress.
  • A modelling pipeline was developed to estimate the disease's burden using local seroprevalence data and spatial analysis in Colombia, projecting 506,000 infected individuals by 2020.
  • Despite a decline in new infections, population growth and aging contributed to an overall increase in Chagas disease cases over time, highlighting the complex dynamics of public health management for neglected tropical diseases.
View Article and Find Full Text PDF